Katrin Mestermann
Impact in
- Oncology top 10%
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 11
- CAR-T cell therapy research 11
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- CRISPR and Genetic Engineering 2
- Co-authors
- Michael Hudecek (11 shared papers)Silke Frenz (4 shared papers)Hermann Einsele (4 shared papers)Thomas Nerreter (3 shared papers)Justus Weber (2 shared papers)Andreas Mades (2 shared papers)Michel Sadelain (1 shared paper)Theodoros Giavridis (1 shared paper)
- Journals
- Blood (2 papers)Current Opinion in Oncology (1 paper)Science Translational Medicine (1 paper)Biotechnology Journal (1 paper)BioDrugs (1 paper)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Katrin Mestermann
10 papers receiving 491 citations
Hit Papers
Peers
Comparison fields: 5 of 40
- Oncology 430
- Immunology 149
- Genetics 139
- Biomedical Engineering 178
- Hematology 29
Countries citing papers authored by Katrin Mestermann
This map shows the geographic impact of Katrin Mestermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Mestermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Mestermann more than expected).
Fields of papers citing papers by Katrin Mestermann
This network shows the impact of papers produced by Katrin Mestermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Mestermann. The network helps show where Katrin Mestermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Katrin Mestermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells Hit paper breakdown → | 2019 | 379 |
| 2 | 2021 | 74 | |
| 3 | 2022 | 22 | |
| 4 | 2020 | 9 | |
| 5 | 2022 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2018 | 1 | |
| 11 | 2020 | 0 |
About Katrin Mestermann
Katrin Mestermann is a scholar working on Oncology, Molecular Biology, Immunology, Genetics and Biomedical Engineering, having authored 11 papers that have together received 493 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Virus-based gene therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Biosimilars and Bioanalytical Methods (2 papers), CRISPR and Genetic Engineering (2 papers), Nanowire Synthesis and Applications (2 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (430 citations), Immunology (149 citations), Genetics (139 citations), Biomedical Engineering (178 citations) and Hematology (29 citations). Katrin Mestermann has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Michael Hudecek, Silke Frenz, Hermann Einsele, Thomas Nerreter, Justus Weber, Andreas Mades, Michel Sadelain, Theodoros Giavridis, Julian Rydzek and Dimitrios Mougiakakos. Their work appears in journals such as Blood, Current Opinion in Oncology, Science Translational Medicine, Biotechnology Journal and BioDrugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.